[Top] [All Lists]

[e-drug] Novartis files a fresh case

E-DRUG: Novartis files a fresh case

Dear friends,
Drug Action Forum - Karnataka, India - an independent, not for profit, NGO 
campaigning for rational drugs has launched "Novartis Boycott" campaign. 
So please sign the online Petition Against Novartis at:
Each one of your signature counts. So please sign and express solidarity on 
this extremely important issue. 
Drug Action Forum - Karnataka had to take this stand as Novartis has filed 
fresh case in the Chennai High Court, India (for details "The Hindu", 
Date:10/08/2007 URL: 
Though Novartis lost the case on Section 3(d), Drug Action Forum - Karnataka 
feels that if public opinion and pressure is not brought on the company, then 
this single case that is currently in the court may have long term implications 
on Access to Medicines topeople all over the world. 
The background goes on like this. During the year 1998, Novartis had filed an 
application, at the Chennai patent office seeking the grant of patents on its 
drug Glivec. Novartis falsely claimed that the drug Glivec was an innovation. 
And rightly the patent application of the Novartis was rejected, under section 
3d of the Indian patent act, by the Indian patent office at Chennai in January 
2006. Novartis did not accept the decision of the Chennai patent office, 
instead challenged this decision of the Patent office in the Chennai high 
court. In addition Novartis also challenged Section (3d) of the Indian patent 
act. If they had won the case then the drug manufactured by Novartis would have 
cost Rupees 1.2 lakh, while Indian drug companies manufacture, the very same 
drug, for Rupees 8,000. The filing of these cases in the Chennai high court by 
Novartis created a huge flutter and a media outcry all over the world. As both 
these cases were rejected by the Chennai high court, it was rejoiced all over 
the world. Novartis also made a statement that they are not going to Supreme 
Court in India or approaching the WTO for dispute settlement. Thus it was 
accepted by people all over the world, that it was a success. 

But Novartis filed a case, not in the Supreme Court, but in the very same 
Chennai high court, stating that the India Patent Appellate Body (IPAB) had 
erred in dismissing its plea to exclude its Technical Member S. Chandrasekaran 
from hearing its legal appeals. The case has been duly admitted in the court 
and is likely to come for hearing on 10th September, mean while till then all 
the proceedings of the Appellate Body came to a grinding halt. The company 
claims that by bringing in a member of the Body, who had earlier filed a case 
against Novartis he is already prejudiced ? as he had earlier filed a petition 
on behalf of the government against the company.  So the company wants some 
body else in place of this person, so that the prejudice is eliminated. 
It is this case at Chennai High court, that has got stuck up that would 
determine the lives of hundreds of millions of people all over the world. 
Helpless and poor people all over the world are watching with intent eyes 
towards these developments, as their very life hangs on these court decisions 
that may even have long term policy implications. As this very case may decide 
and change the way the Section 3 (d) of the Indian act is interpreted. This is 
an act that shelves frivolous patents. 

Because there are around 9,000 applications that are pending in the Patent 
office, seeking grants of patents. And no wonder many of these applications 
would be like the one that is not a real and genuine innovation. But just few 
minute changes made in the drug ? which is known as ?ever greening? of patents, 
thus wanting to be just rejected.

Even the scientist Brian Druker, who was involved in discovering this drug has 
come out openly against the company as he feels that the price at which Glivec 
has been offered for sale by Novartis is cause for considerable discomfort. 

Dr Gopal Dabade,
Drug Action Forum ? Karnataka,
57, Tejaswinagar, 
Dharwad 580 002, INDIA
Mobile +91 (0)9448862270

<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] Novartis files a fresh case, Dr Gopal Dabade <=